Cuu Long Pharmaceutical JSC

13
Strong Sell
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: VN000000DCL1
VND
40,050.00
-100 (-0.25%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Million
Consolidated - Profit And Loss Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Operating Income
13,06,797.00
11,43,946.00
10,15,685.00
7,03,634.00
6,71,246.00
7,52,014.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
13,06,797.00
11,43,946.00
10,15,685.00
7,03,634.00
6,71,246.00
7,52,014.00
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
Raw Materials Consumed
0.00
0.00
0.00
0.00
0.00
0.00
Power & Fuel Cost
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
1,20,461.00
1,25,358.00
1,32,956.00
1,21,564.00
1,14,617.00
1,32,907.00
Operating Expenses
25,494.00
30,530.00
36,283.00
36,476.00
34,471.00
37,582.00
General and Administration Expenses
1,40,266.00
1,34,824.00
1,50,090.00
1,20,531.00
1,35,987.00
1,67,321.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
12,46,967.00
10,73,220.00
8,87,400.00
6,16,853.00
6,23,342.00
7,39,226.00
Operating Profit (PBDIT) excl Other Income
59,830.00
70,725.00
1,28,285.00
86,780.00
47,904.00
12,787.00
Other Income
34,441.00
37,915.00
49,539.00
59,979.00
72,511.00
1,29,527.00
Operating Profit (PBDIT)
1,32,528.00
1,46,919.00
2,15,959.00
1,81,033.00
1,48,695.00
1,81,932.00
Interest
25,494.00
30,530.00
36,283.00
36,476.00
34,471.00
37,582.00
Profit before Depriciation and Tax
0.00
0.00
0.00
0.00
0.00
0.00
Depreciation
38,257.00
38,278.00
38,134.00
34,273.00
28,279.00
39,617.00
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
68,776.00
78,110.00
1,41,541.00
1,10,284.00
85,944.00
1,04,732.00
Provision for Tax
14,631.00
15,976.00
28,627.00
22,527.00
17,016.00
17,729.00
Profit After Tax
53,571.00
61,717.00
1,11,640.00
85,960.00
66,391.00
88,473.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
0.00
0.00
0.00
0.00
0.00
0.00
Profit Available for appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Equity Dividend (%)
Earnings Per Share
733.44
844.97
1,591.22
1,494.98
966.21
1,244.21
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is 14.24% vs 12.63% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is -15.41% vs -44.87% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is -16.50% vs -15.85% in Dec 2023

stock-summary

Profit After Tax

YoY Growth in year ended Dec 2024 is -13.20% vs -44.72% in Dec 2023

Compare Profit and Loss Results of Cuu Long Pharmaceutical JSC
Markets Mojo
Figures in Million
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(VND)
Change(%)
No of Months
12
12
Operating Income
13,06,797.00
19,53,658.00
-6,46,861.00
-33.11%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
13,06,797.00
19,53,658.00
-6,46,861.00
-33.11%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0%
Raw Materials Consumed
0.00
0.00
0.00
0%
Power & Fuel Cost
0.00
0.00
0.00
0%
Employee Cost
1,20,461.00
2,43,659.00
-1,23,198.00
-50.56%
Operating Expenses
25,494.00
53,561.00
-28,067.00
-52.40%
General and Administration Expenses
1,40,266.00
2,59,799.00
-1,19,533.00
-46.01%
Selling and Distribution Expenses
0.00
0.00
0.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
12,46,967.00
19,14,357.00
-6,67,390.00
-34.86%
Operating Profit (PBDIT) excl Other Income
59,830.00
39,300.00
20,530.00
52.24%
Other Income
34,441.00
2,41,952.00
-2,07,511.00
-85.77%
Operating Profit (PBDIT)
1,32,528.00
4,23,021.00
-2,90,493.00
-68.67%
Interest
25,494.00
53,561.00
-28,067.00
-52.40%
Profit before Depriciation and Tax
0.00
0.00
0.00
0%
Depreciation
38,257.00
1,41,768.00
-1,03,511.00
-73.01%
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
68,776.00
2,27,691.00
-1,58,915.00
-69.79%
Provision for Tax
14,631.00
51,187.00
-36,556.00
-71.42%
Profit After Tax
53,571.00
1,19,263.00
-65,692.00
-55.08%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
0.00
0.00
0.00
0%
Profit Available for appropriations
0.00
0.00
0.00
0%
Appropriations
0.00
0.00
0.00
0%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
733.4384
350.8443
382.59
109.05%
Profit And Loss - Net Sales
Net Sales 13,06,797.44 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 14.24% vs 12.63% in Dec 2023

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 59,830.20 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -15.41% vs -44.87% in Dec 2023

Profit And Loss - Interest
Interest 25,494.46 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -16.50% vs -15.85% in Dec 2023

Profit And Loss - Profit After Tax
Profit After Tax 53,571.10 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -13.20% vs -44.72% in Dec 2023